Active, Not Recruiting
NP-101 (TQ Formula) With Nivolumab and Ipilimumab in Advanced or Metastatic Extra-pulmonary Neuroendocrine Carcinomas
NCT05262556
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +12 more
- Locations
-
- University hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States